-
UK Residents Transplanted Overseas: A Summary of UK Data from 2000-2016
-
Uncontrolled DCD vs DBD Liver Transplantation in the United States: Is it Safe to Push the Envelope?
-
Uncovering Factors That Lead to an Increase in Significant Early Rejection Outcomes in Cardiac Transplant Patients
-
Under-Diagnosed Hyperoxalosis in Transplant-Listed Patients
-
Undernutrition and Hypoleptinemia Modulate Cytomegalovirus Infection
-
Understanding Attitudes and Perceptions about Liver Disease and Living-Donor Liver Transplant- Results of a National Survey
-
Understanding the Decision-Making of 2576 Potential Living Kidney Donors of Different Racial/Ethnic Backgrounds
-
Understanding the Molecular Phenotype of Kidney Injury
-
Understanding the Relationship between Health Literacy, Education Level, and Transplant Actions among Low-Income and Black Patients
-
Unexpected Regulation of Foxp3+ Treg Production, Stability and Function by the Nuclear Co-Repressor, Sin3A
-
Unified Management of Inferior Vena Cava Web and Right Hepatic Vein in Living Donor Liver Transplantation for Membranous Obstruction of Vena Cava (Budd Chiari Syndrome)
-
Unique Genomic & Proteomic Profile of Liver Mesenchymal Stromal Cells is Associated with Their Superior Immunomodulatory Properties
-
Unique Podocyte and Multiplex Single-Cell RNASeq Analysis of Paired Sera and Bone Marrow Samples Suggest a Role for Perturbed Hematopoeitic Progenitors in FSGS Recurrence
-
UNOS Hard to Place Kidneys: Are We Working Too Hard?
-
UNOS Registry Myocarditis Heart Transplantation Outcome
-
Unrealized Potential Utilization of HCV+ Deceased-Donor Kidneys and Livers
-
Unresolved Disparities: Sex, Racial, Ethnic, and Insurance Differences in Performance Status at Listing for Liver Transplant
-
Unsupervised Analysis of the Alloimmune Response Using Single-Cell Mass Cytometry
-
Unusual Case of Delayed Onset Proteinuria in AT1R Antibody Mediated Rejection
-
Uremic Symptoms: A Patient-Reported Outcome That is Associated with Access to Kidney Transplantation and Waitlist Mortality among Kidney Transplant Candidates
-
Ureteral Complications Post Kidney Transplantation – Incidence and Preferred Treatment Modality
-
Urinary APOA4 as a Biomarker for Chronic Renal Allograft Injury and Rapid Renal Function Decline in Kidney Transplant Recipients
-
Urinary CXCL10: From Diagnosis to Prediction of BK Viremia in Kidney Transplantation
-
Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients
-
Urine Donor Derived Cell Free DNA Aids in the Diagnosis of BK Polyomavirus Nephropathy in Kidney Transplant Recipients with BK Viruria
-
Uromodulin to Osteopontin Ratio in Deceased Donor Urine is Associated with Kidney Graft Outcomes
-
Use of 16S Sequencing to Reveal Potential Respiratory Pathogens in Lung Transplant Recipients
-
Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Therapy Prior to Kidney Transplantation Does Not Impact Recovery of Function
-
Use of Cell Saver Leads to Lower Consumption of Blood Products During Liver Transplantation
-
Use of Direct Acting Antiviral Medications in Transplant Recipients Receiving Organs from Hepatitis C Viremic Donors
-
Use of Donor-Derived Cell-Free DNA Assay to Monitor Treatment Response to Allograft Rejection in Pediatric Renal Transplant Recipients
-
Use of ICG Fluorescent Imaging in the Assessment of Kidney Transplant Perfusion after a Vascular Complication Requiring Complex Vascular Reconstruction
-
Use of Letermovir for Cytomegalovirus Management in Thoracic Organ Transplantation
-
Use of Sitagliptin versus Placebo to Reduce the Incidence and Severity of Post-Transplant Diabetes after Kidney Transplantation
-
Use of Subunit Herpes Zoster Vaccine in VZV-Seronegative Transplant Recipients to Prevent Primary Varicella
-
Use of Tacrolimus Extended-Release in Elderly Kidney Transplant Recipients
-
Use of tCRM to Aid Diagnosis of Allograft Rejection in Kidney Transplantation
-
Using an Ex Vivo Blood-Free Model of Preservation and Reperfusion to Evaluate the Effects of Subnormothermic Perfusion with Hydrogen Sulfide on DCD Porcine Renal Grafts
-
Using Artificial Intelligence Tools for Identification of High Risk Transplant Recipients for Focused Management
-
Using HCV Infected Organs and the Challenge of Third-Party Payers
-
Using Nudges for Liver Transplantation Prehabilitation: Results from PRIMER (Prehabilitation Intervention to Maximize Early Recovery), a Home-Based Behavioral Pilot and Feasibility Trial
-
Using Personal Contact with Donors and Recipients to Bridge Disparities in Native American Organ Donation and Transplantation
-
Using Quality Metrics to Improve Access to Living Donor Kidney Transplantation
-
Using Trajectory Analysis to Characterize Trends in OPO Performance with Population-Based Metrics
-
Utility of Bimonthly Viral Monitoring for Late-Onset Cytomegalovirus Infections in Kidney Transplant Recipients
-
Utility of dd-cfDNA in TCMR 1A and Borderline Allograft Rejection
-
Utility of Estimated Glomerular Filtration Rate in Living Kidney Donor Candidates
-
Utilization and Outcomes of Simultaneous Liver-Kidney Transplants after Change in Allocation Policy
-
Utilization of Direct Acting Oral Anticoagulation in Solid Organ Transplant Patients: A National Survey of Institutional Practices
-
Utilization of Hepatitis C Positive Organs in Kidney Transplantation
-
Utilization of Hepatitis C Viremic Donors in Liver Transplantation. A Single Center Experience
-
Utilization of High Terminal Creatinine Kidney Donors for Simultaneous Kidney and Pancreas Transplantation
-
Utilization of Kidneys from Deceased Donors with Positive Hepatitis C Nucleic Acid Amplification Testing (HCV NAT+)
-
Utilization of Kidneys with Microthrombi and Acute Kidney Injury
-
Utilization of Mechanical Circulatory Support Devices and Impact on Outcomes in the New Heart Allocation System: An Analysis of the UNOS Registry
-
Utilization of Organs from Donors Exposed to Hepatitis C: ? Standard of Care
2020 American Transplant Congress
May 30-June 1, 2020
ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021
Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.